N-(4-(azaindazol-6-yl)-phenyl)-sulfonamides and their use as pharmaceuticals

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9718825
APP PUB NO 20160024097A1
SERIAL NO

14775620

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to N-(4-(azaindazol-6-yl)-phenyl)-sulfonamides of the formula I,

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SANOFI75017 PARIS

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Halland, Nis Frankfurt am Main, DE 19 73
Kleemann, Heinz-Werner Frankfurt am Main, DE 116 826
Nazare, Marc Frankfurt am Main, DE 42 431
Saas, Joachim Frankfurt am Main, DE 4 1
Schmidt, Friedemann Frankfurt am Main, DE 12 42
Struebing, Carsten Frankfurt am Main, DE 7 5
Weiss, Tilo Frankfurt am Main, DE 10 33

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 1, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 1, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00